Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?

BACKGROUND: Atopic dermatitis (AD or eczema) is a most common chronic skin disease. Designing personalised treatment strategies for AD based on patient stratification is of high clinical relevance, given a considerable variation in the clinical phenotype and responses to treatments among patients. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurault, G., Roekevisch, E., Schram, M. E., Szegedi, K., Kezic, S., Middelkamp‐Hup, M. A., Spuls, P. I., Tanaka, R. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060148/
https://www.ncbi.nlm.nih.gov/pubmed/35665204
http://dx.doi.org/10.1002/ski2.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060148/
https://www.ncbi.nlm.nih.gov/pubmed/35665204
http://dx.doi.org/10.1002/ski2.77

Ejemplares similares